🔥🐔 BizChicken 🐔🔥
Companies Similar to Neumora Therapeutics, Inc. Common Stock
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Athira Pharma, Inc.
ATH-1017
Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, with its lead product, ATH-1017, in clinical trials for Alzheimer's and Parkinson's diseases.
Symbol: ATHA
Recent Price: $0.55
Industry: Biotechnology
CEO: Dr. Mark J. Litton M.B.A., Ph.D.
Sector: Healthcare
Employees: 65
Address: 18706 North Creek Parkway, Bothell, WA 98011
Phone: 425 620 8501
Last updated: 2024-12-31
CARGO Therapeutics, Inc. Common Stock
CRG-022
CARGO Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing chimeric antigen receptor (CAR) T-cell therapies for cancer patients. Their lead program, CRG-022, targets resistance mechanisms in B-cell malignancies.
About | Leadership | Directors | About | Contact | Contact | Careers | Careers | Careers | Careers | About | About
Symbol: CRGX
Recent Price: $13.76
Industry: Biotechnology
CEO: Ms. Gina Chapman
Sector: Healthcare
Employees: 150
Address: 1900 Alameda De Las Pulgas, San Mateo, null 94403
Phone: 650-379-6143
Leadership
- Gina Chapman, President and Chief Executive Officer
- Anup Radhakrishnan, Chief Financial Officer/Chief Business Officer
- Ginna Laport, MD, Chief Medical Officer
- Shishir Gadam, PhD, Chief Technical Officer
- Michael Ports, PhD, Chief Scientific Officer
- Kari Leetch, Chief People Officer
- Halley Gilbert, JD, Chief Legal Officer
- Bethany Rogers, SVP, Product Strategy and Commercialization
- Faisal Shawwa, SVP, Finance
- Tonia J. Buchholz, PhD, Head of Clinical Science
- Kanika Chawla, PhD, Head of Process Sciences
- Sandra Chen, Head of Clinical Quality and Risk Management
- Michelle Gray, Head of Clinical Operations
- Adam Haskett, Head of External Manufacturing
- David Hoffman, JD, Head of Intellectual Property & Transactions
- Anissa Irwin, Head of Quality Assurance and Systems
- Brett Masterson, Head of Marketing
- Rob McCombie, Head of CMC Regulatory
- Frank McDonald, Head of Clinical Data Management
- Priya Parameswaran, Head of Corporate Strategy and Business Operations
- Shabnum Patel, PHD, Head of MSAT
- Mary Rodley, Head of CMC Strategy and Operations
- Abhijeet Sarvaiya, Head of Statistical Programming
- Brian Schoelkopf, Head of FP&A
- Christophe Suchet, Head of IT
- Beth Vasievich, PhD, Head of Commercial Planning and Operations
- Jun Wang, Head of Procurement
- John Orwin, Chairman of the Board
- Abraham Bassan, Board Director
- Kapil Dhingra, M.B.B.S, Board Director
- Reid Huber, PHD, Board Director
- David Lubner, Board Director
- Krishnan Viswanadhan, Pharm.D, Board Director
- Jane Pritchett Henderson, Board Director
Last updated: 2024-12-31
Capricor Therapeutics, Inc.
CAP-1002
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company specializing in developing transformative cell and exosome-based therapeutics aimed at treating and preventing a range of diseases and disorders. Their lead candidate, CAP-1002, is designed for Duchenne muscular dystrophy and cytokine storm interventions.
About | Leadership | Directors | About | About | Contact | Careers | About | About | About | About
Symbol: CAPR
Recent Price: $13.76
Industry: Biotechnology
CEO: Dr. Linda Marbán Ph.D.
Sector: Healthcare
Employees: 101
Address: 10865 Road to the Cure, San Diego, CA 92121
Phone: 310 358 3200
Leadership
- Linda Marbán, Ph.D., Chief Executive Officer and Director
- Kristi A. H. Elliott, Ph.D., Chief Science Officer
- AJ Bergmann, M.B.A., Chief Financial Officer
- Karen G. Krasney, J.D., Executive Vice President and General Counsel
- Mark Awadalla, Vice President of Clinical Operations
- Jonathan Tayco, Vice President of Program Management and Business Operations
- Minghao Sun, Ph.D., Vice President of Research and Product Development
- Yushi Feng, Ph.D., Vice President of Regulatory Affairs
- Frank Litvack M.D., FACC, Executive Chairman
- Paul G. Auwaerter, M.D., M.B.A., FIDSA, Director
- Earl M. (Duke) Collier Jr., Director
- George W. Dunbar, Jr., Director
- Philip J. Gotwals, Ph.D., Director
- Michael Kelliher, Director
- David B. Musket, Director
- Karimah Es Sabar, Director
Last updated: 2024-12-31
Neurocrine Biosciences, Inc.
INGREZZA
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for various conditions, focusing on innovative solutions for unmet medical needs.
Symbol: NBIX
Recent Price: $137.06
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Kyle W. Gano Ph.D.
Sector: Healthcare
Employees: 1700
Address: 12780 El Camino Real, San Diego, CA 92130
Phone: 858 617 7600
Last updated: 2024-12-31
Neumora Therapeutics, Inc. Common Stock
navacaprant (NMRA-140)
Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. Key programs include navacaprant for major depressive disorder, and several promising treatments in various stages of clinical and preclinical trials targeting conditions such as Alzheimer's, schizophrenia, and Parkinson's disease.
About | About | Contact | Careers | Careers | Careers | About | About | About | About | About | Careers | About | About | About | Careers | Jobs
Symbol: NMRA
Recent Price: $11.06
Industry: Biotechnology
CEO: Mr. Henry O. Gosebruch
Sector: Healthcare
Employees: 108
Address: 490 Arsenal Way, Watertown, null 02472
Phone: 857 760 0900
Last updated: 2024-12-31
Alzamend Neuro, Inc.
AL001 and AL002
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing products for neurodegenerative and psychiatric disorders. Their pipeline includes AL001 for Alzheimer's and psychiatric disorders, and AL002 for Alzheimer's disease using a novel vaccine approach.
About | About | Contact | Contact | Contact | Contact | Careers | About | About | About | About | About
Symbol: ALZN
Recent Price: $1.20
Industry: Biotechnology
CEO: Mr. Stephan Jackman
Sector: Healthcare
Employees: 4
Address: 3500 Lenox Road NE, Atlanta, GA 30326
Phone: 844 722 6333
Last updated: 2024-12-31
Axsome Therapeutics, Inc.
AXS-05, AXS-07, AXS-12, AXS-14
Axsome Therapeutics, Inc. is a biopharmaceutical company focused on developing novel therapies for central nervous system disorders such as major depressive disorder, migraine, narcolepsy, and fibromyalgia.
About | Leadership | Directors | About | About | About | About | About | About | Contact | Careers | Careers | About | About
Symbol: AXSM
Recent Price: $84.78
Industry: Biotechnology
CEO: Dr. Herriot Tabuteau M.D.
Sector: Healthcare
Employees: 589
Address: 22 Cortlandt Street, New York, NY 10007
Phone: 212 332 3241
Leadership
- Herriot Tabuteau, MD, CHIEF EXECUTIVE OFFICER
- Nick Pizzie, CPA, MBA, CHIEF FINANCIAL OFFICER
- Mark Jacobson, MA, CHIEF OPERATING OFFICER
- Hunter Murdock, Esq., GENERAL COUNSEL
- ari Maizel, Executive Vice President, Head of Commercial
- Mark Coleman, MD, DIRECTOR
- Roger Jeffs, PhD, DIRECTOR
- Susan Mahony, PhD, MBA, DIRECTOR
- Mark Saad, DIRECTOR
Last updated: 2024-12-31
CervoMed Inc.
neflamapimod
Cervo Med Inc. is a clinical-stage biotechnology company focused on developing and commercializing drug treatments for neurodegenerative diseases, including neflamapimod for conditions like dementia with Lewy bodies, Alzheimer's diseases, and brain stroke recovery.
Symbol: CRVO
Recent Price: $2.39
Industry: Biotechnology
CEO: Dr. John J. Alam M.D.
Sector: Healthcare
Employees: 8
Address: 20 Park Plaza, Boston, MA 02116
Phone: 617-744-4400
Last updated: 2024-12-31
Intra-Cellular Therapies, Inc.
CAPLYTA
Intra-Cellular Therapies, Inc. is a biopharmaceutical company focused on developing novel drugs for the treatment of neuropsychiatric and neurologic diseases targeting intracellular signaling in the central nervous system. Key products include CAPLYTA for schizophrenia and ongoing developments in treatments for bipolar depression, autism spectrum disorder, and more.
About | About | Leadership | Directors | Sustainability | Contact | Careers | Careers | About | News | About | Careers
Symbol: ITCI
Recent Price: $83.48
Industry: Drug Manufacturers - Specialty & Generic
CEO: Dr. Sharon Mates Ph.D.
Sector: Healthcare
Employees: 610
Address: 430 East 29th Street, New York, NY 10016
Phone: 646 440 9333
Leadership
- Sharon Mates, Ph.D., Chairman, Founder & Chief Executive Officer
- Michael I. Halstead, J.D., President
- Mark Neumann, Executive Vice President, Chief Commercial Officer
- Suresh Durgam, M.D., Executive Vice President, Chief Medical Officer
- Sanjeev Narula, Executive Vice President, Chief Financial Officer
- John A. Bardi, Senior Vice President, Market Access, Policy and Government Affairs
- Robert E. Davis, Ph.D., Senior Vice President, Chief Scientific Officer
- Karen Sheehy, Esq., Senior Vice President and Chief Compliance Officer
- Michael Olchaskey, Pharm.D., Senior Vice President, Head of Regulatory Affairs
- Juan Sanchez, M.D., Vice President of Corporate Communications and Investor Relations
- Willie R. Earley, M.D., Senior Vice President, Head of Clinical Development
- Joel S. Marcus, J.D., CPA, Executive Chairman & Founder
- Rory B. Riggs, MBA, Co-Founder and Director
- E. Rene Salas, CPA, Former Senior Client Partner at Ernst & Young, LLP; Former CFO, Wellstat, LLC
- Robert L. Van Nostrand, Chairman, Metabolix; Board Member, Achillion Pharmaceuticals; Former CFO, OSI Pharmaceuticals
Last updated: 2024-12-31
Minerva Neurosciences, Inc.
Roluperidone
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing treatments for central nervous system diseases, including schizophrenia and Parkinson's disease.
Symbol: NERV
Recent Price: $2.29
Industry: Biotechnology
CEO: Dr. Remy Luthringer Ph.D.
Sector: Healthcare
Employees: 9
Address: 1601 Trapelo Road, Waltham, MA 02451
Phone: 617 600 7373
Leadership
- Remy Luthringer, PhD, Executive Chairman of the Board, Chief Executive Officer
- Geoff Race, FCMA, MBA, President
- Michael Davidson, M.D., Chief Medical Officer
- Frederick Ahlholm, CPA, Chief Financial Officer
- Joseph Reilly, Senior Vice President and Chief Operating Officer
- Jay Saoud, PhD, Consultant
- Hans Peter Hasler, Board Member
- Jan van Heek, Board Member
- David Kupfer, MD, Board Member
- Fouzia Laghrissi-Thode, MD, Board Member, Chief Executive Officer of DalCor Pharmaceuticals
Last updated: 2024-12-31
Neurogene Inc.
NGN-401, NGN-101
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases, focusing on gene therapy products like NGN-401 for Rett syndrome and NGN-101 for neuronal ceroid lipofuscinosis subtype 5 batten disease.
About | Contact | Contact | Careers | Jobs | Jobs | Jobs | Benefits | Jobs | Jobs | Jobs | Jobs | Careers | About | About | About
Symbol: NGNE
Recent Price: $22.28
Industry: Biotechnology
CEO: Dr. Rachel L. McMinn Ph.D.
Sector: Healthcare
Employees: 91
Address: 535 W 24th Street, New York, NY 10011
Phone: (877) 237-5020
Last updated: 2024-12-31
Nkarta, Inc.
NKX101 and NKX019
Nkarta, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing cell therapies for the treatment of cancer. The company specializes in cellular immunotherapy using chimeric antigen receptors on natural killer cells to target tumor antigens.
About | Contact | Careers | Careers | Careers | Jobs | Careers | Careers | Careers | Careers | Careers | Careers | Contact | Careers | About | Careers
Symbol: NKTX
Recent Price: $2.32
Industry: Biotechnology
CEO: Mr. Paul J. Hastings
Sector: Healthcare
Employees: 150
Address: 6000 Shoreline Court, South San Francisco, CA 94080
Phone: 415 582 4923
Last updated: 2024-12-31
NeuroBo Pharmaceuticals, Inc.
ANA001
A clinical-stage biotechnology company developing therapies for neurodegenerative, infectious, and cardiometabolic diseases.
Symbol: NRBO
Recent Price: $2.36
Industry: Biotechnology
CEO: Mr. Hyung-Heon Kim
Sector: Healthcare
Employees: 8
Address: 200 Berkeley Street, Boston, MA 02116
Phone: 857 702 9600
Last updated: 2024-12-31
REGENXBIO Inc.
NAV Technology Platform
REGENXBIO Inc. is a biotechnology company focusing on gene therapy product candidates to treat genetic defects and enable therapeutic protein production, using its proprietary NAV Technology Platform. Its lead candidate, RGX-314, is in Phase III trials for wet age-related macular degeneration.
Symbol: RGNX
Recent Price: $7.23
Industry: Biotechnology
CEO: Mr. Curran M. Simpson M.S.
Sector: Healthcare
Employees: 344
Address: 9804 Medical Center Drive, Rockville, MD 20850
Phone: 240 552 8181
Last updated: 2024-12-31
Cartesian Therapeutics, Inc.
SEL-302, SEL-212
Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing nanoparticle immunomodulatory drugs for treating and preventing human diseases. The company has various programs including gene therapies and biologic therapies for conditions like methylmalonic acidemia and chronic refractory gout.
Symbol: RNAC
Recent Price: $18.76
Industry: Biotechnology
CEO: Dr. Carsten Brunn Ph.D.
Sector: Healthcare
Employees: 37
Address: 65 Grove Street, Watertown, MA 02472
Phone: 617 923 1400
Last updated: 2024-12-31
Titan Pharmaceuticals, Inc.
Pro Neura
Titan Pharmaceuticals, Inc. is a pharmaceutical company developing therapeutics for chronic diseases utilizing the Pro Neura drug delivery platform. Its products include the Probuphine implant for opioid use disorder treatment, among other programs for chronic pruritus, opioid relapse prevention, HIV prevention, and contraception.
About | About | Leadership | Directors | About | Contact | Directors | Directors | Directors | Careers | About
Symbol: TTNP
Recent Price: $3.40
Industry: Biotechnology
CEO: Jennifer Kiernan
Sector: Healthcare
Employees: 4
Address: 400 Oyster Point Boulevard, South San Francisco, CA 94080-1958
Phone: 650 244 4990
Leadership
- Dato’ Seow Gim Shen, Chief Executive Officer and Chairman of the Board of Directors
- Avraham Ben-Tzvi, Founder
- Brynner Chiam, Vice President of Finance and Tax
- Firdauz Edmin Bin Mokhtar, Chief Executive Officer
- Francisco Osvaldo Flores García, Managing Partner
Last updated: 2024-12-31
Arcturus Therapeutics Holdings Inc.
RNA medicines
Arcturus Therapeutics Holdings Inc. focuses on developing vaccines for infectious and rare diseases, including programs for cystic fibrosis and ornithine transcarbamylase deficiency. The company collaborates with various partners for vaccine and therapeutic development.
Symbol: ARCT
Recent Price: $16.58
Industry: Biotechnology
CEO: Mr. Joseph E. Payne M.Sc.
Sector: Healthcare
Employees: 180
Address: 10628 Science Center Drive, San Diego, CA 92121
Phone: 858 900 2660
Last updated: 2024-12-31
Cadrenal Therapeutics, Inc. Common Stock
Tecarfarin
Cadrenal Therapeutics, Inc. is a clinical development biopharmaceutical company focusing on novel therapies for preventing systemic thromboembolism in patients with specific health conditions, headquartered in Ponte Vedra, Florida.
Symbol: CVKD
Recent Price: $14.23
Industry: Biotechnology
CEO: Mr. Quang X. Pham
Sector: Healthcare
Employees: 4
Address: 822 A1A North, Ponte Vedra, FL 32082
Phone: 904 300 0701
Last updated: 2024-12-31
Nuvectis Pharma, Inc.
NXP800, NXP900
Nuvectis Pharma, Inc., is a biopharmaceutical company that focuses on developing precision medicines for treating serious unmet medical needs in oncology. It is working on products like NXP800, a heat shock factor 1 pathway inhibitor, and NXP900, a drug candidate targeting Proto-oncogene c-Src and YES1 kinases.
Symbol: NVCT
Recent Price: $5.14
Industry: Biotechnology
CEO: Mr. Ron Bentsur M.B.A.
Sector: Healthcare
Employees: 13
Address: 1 Bridge Plaza, Fort Lee, NJ 07024
Phone: 201 614 3150
Last updated: 2024-12-31
Viracta Therapeutics, Inc.
Nana-val
Viracta Therapeutics, Inc. is a precision oncology company focused on developing drugs for the treatment of virus-associated malignancies, with a lead product candidate Nana-val in clinical trials for Epstein-Barr virus-positive lymphoma and other related conditions.
Leadership | Contact | Careers | About | Careers | About | About | About | About | About | About
Symbol: VIRX
Recent Price: $0.16
Industry: Biotechnology
CEO: Mr. Mark Andrew Rothera
Sector: Healthcare
Employees: 40
Address: 2533 South Coast Highway 101, Cardiff-by-the-Sea, CA 92007
Phone: 858 400 8470
Leadership
- Mark Rothera, President and Chief Executive Officer
- Darrel P. Cohen, M.D., Ph.D., Chief Medical Officer
- Ayman Elguindy, Ph.D., Chief Scientific Officer
- Michael Faerm, MBA, Chief Financial Officer
- Cheryl Madsen, Senior Vice President, Regulatory
- Patric Nelson, MBA, Senior Vice President, Business Development & Corporate Strategy
- Biljana Nadjsombati, Pharm.D., Senior Vice President, Pharmaceutical Development
- Violetta Akopian, Ph.D., Vice President, Quality Assurance
- Ruby Cheema, Vice President, Portfolio and Program Management
- Mark A. McCamish, M.D., Ph.D., Strategic Advisor
- Roger J. Pomerantz, M.D., Chairman of the Board
- Jane F. Barlow, M.D., MPH, MBA, Director
- Flavia Borellini, Ph.D., Director
- Jane Chung, R.Ph., Director
- Thomas E. Darcy, CPA, Director
- Sam Murphy, Ph.D., Director
- Ivor Royston, M.D., Director
- Stephen Rubino, Ph.D., MBA, Director
- Barry J. Simon, M.D., Director
- Douglas V. Faller, M.D., Ph.D., Scientific Founder and Chairman, Scientific Advisory Board
- Robert Baiocchi, M.D., Ph.D., Scientific Advisor
- Gavin Giovannoni, MBBCh, Ph.D., FCP (Neurol., SA), FRCP, FRCPath, Scientific Advisor
- Carl June, M.D., Scientific Advisor
- Shannon Kenney, M.D., Scientific Advisor
- Ronald Levy, M.D., Scientific Advisor
- Pierluigi Porcu, M.D., Scientific Advisor
- Daniel D. Von Hoff, M.D., F.A.C.P. FASCO, FAACR, Scientific Advisor
- Lawrence Young, Ph.D., Scientific Advisor
Last updated: 2024-12-31